Post by AGC Biologics

129,462 followers

How can biologics developers benefit from a ๐ฌ๐œ๐š๐ฅ๐ž-๐จ๐ฎ๐ญ ๐ฆ๐š๐ง๐ฎ๐Ÿ๐š๐œ๐ญ๐ฎ๐ซ๐ข๐ง๐  ๐ฌ๐ญ๐ซ๐š๐ญ๐ž๐ ๐ฒ? Anders Cai Holm Hansen, Principal Scientist Customer Solution Design at AGC Biologics, recently sat down for an interview with BioSpace to discuss our single-use technology (SUT) network and strategy emphasizing โ€œscale-outโ€ manufacturing. Read the article and discover how this approach, including high-yield perfusion processes, helps developers derisk demand uncertainty while accelerating timelines and lowering costs. https://hubs.ly/Q04f7Lln0 #SingleUseTechnology #yourfriendlyCDMOexpert

Post contentPost contentPost content